Latest News in the pharma Industry
Research & Development
.jpg)
Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19
16 Mar 2020
The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.
Read more
Sartorius simplifies biologics production with new bioreactor
9 Mar 2020
Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.
Read more.jpg)
Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial
9 Mar 2020
Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.
Read more.jpg)
Nanoform and Orion collaborate on 'nanoformed' APIs
9 Mar 2020
Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.
Read more.jpg)
Thermo Fisher Scientific to acquire Qiagen
3 Mar 2020
Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.
Read more.jpg)
Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven
3 Mar 2020
Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.
Read more.jpg)
MindMed becomes world's first psychedelic pharma company to go public
3 Mar 2020
The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.
Read more.jpg)
Potential first-in-class treatment reaches significant milestone
2 Mar 2020
The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.
Read more.jpg)
Merck KGaA, AMCM/EOS co-operate in 3D printing of tablets
27 Feb 2020
A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ...
Read more.jpg)
BIA Separations signs agreement to commercialise novel elution technology
26 Feb 2020
Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy.
Read more.jpg)
Non-hormonal treatment for menopausal hot flashes begins clinical trials
25 Feb 2020
The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life.
Read more.jpg)
Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD
21 Feb 2020
Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.
Read more